Category
Biologics & Advanced Therapies
Guides to IBD biologics and advanced therapies such as Entyvio, Skyrizi, Stelara, Tremfya and Rinvoq: dosing, side effects, comparisons and access.
Skyrizi vs Entyvio for Crohn's Disease: A Patient Guide
Skyrizi vs Entyvio for Crohn's: compare efficacy, safety, onset and dosing, including week 12 vs 14 response checks, to prepare for your GI visit.
Skyrizi vs Entyvio for Ulcerative Colitis: A Comparison
Skyrizi vs Entyvio for ulcerative colitis: compare efficacy, onset, safety and dosing, including week 12 vs 14 response checks. Prepare for your GI visit.
Skyrizi vs Humira for Crohn's Disease: Comparing Options
Skyrizi vs Humira for Crohn's: compare efficacy, safety, onset, cost and dosing, including IV induction vs home injections, to prepare for your GI visit.
Skyrizi vs Humira for Ulcerative Colitis: What to Know
Skyrizi vs Humira for ulcerative colitis: compare efficacy, safety and SC maintenance every 8 weeks vs every other week. Prepare questions for your GI.
Skyrizi vs Omvoh for Crohn's Disease: A Comparison
Skyrizi vs Omvoh for Crohn's: compare trial evidence, safety, and every-8-week vs every-4-week maintenance dosing to prepare for your GI visit.
Skyrizi vs Omvoh for Ulcerative Colitis: A Comparison
Compare Skyrizi vs Omvoh for ulcerative colitis, including remission data, bowel urgency, safety, and every-8-week vs every-4-week dosing.
Skyrizi vs Remicade for Crohn's Disease: Which Is Better?
Skyrizi vs Remicade for Crohn's: compare efficacy, onset, infection risk, cost, and IV vs SC maintenance. Prepare for your GI visit.
Skyrizi vs Remicade for Ulcerative Colitis: Patient Guide
Skyrizi vs Remicade for ulcerative colitis: compare efficacy, onset, safety, dosing, costs and switching considerations to prepare for your GI visit.
Skyrizi vs Stelara for Crohn's Disease: SEQUENCE Trial Results
Skyrizi vs Stelara for Crohn's: compare SEQUENCE's 59% vs 40% clinical remission results, plus endoscopic outcomes, safety and dosing.
Skyrizi vs Stelara for Ulcerative Colitis: A Comparison
Skyrizi vs Stelara for ulcerative colitis: compare trial evidence, safety, onset and every-8-week dosing, then prepare questions for your GI.
Skyrizi vs Tremfya for Crohn's Disease: Which Is Right?
Compare Skyrizi vs Tremfya for Crohn's disease by trial evidence, dosing, injection devices, safety and access, including Tremfya's SC induction.
Skyrizi vs Tremfya for Ulcerative Colitis: Comparing IL-23s
Skyrizi vs Tremfya for ulcerative colitis: compare week 12 remission data, IV vs SC induction, maintenance dosing, safety, and injection devices.
Starting an IL-23 Medication for IBD: Induction, Maintenance, and Response Tracking
IL-23 medications for IBD follow induction at weeks 0, 4, and 8 before maintenance. Compare Skyrizi, Omvoh, and Tremfya and learn what to track.
Stelara vs Humira for Crohn's Disease: Which Biologic Is Right?
Stelara vs Humira for Crohn's: compare 52-week SEAVUE remission rates, infection risks, dosing schedules and switching guidance for your GI visit.
Stelara vs Humira for Ulcerative Colitis: Key Differences
Compare Stelara and Humira for ulcerative colitis on efficacy, safety, response time and maintenance dosing every 2 vs 8 weeks. Prepare for your GI visit.
Stelara vs Remicade for Crohn's Disease: Comparing Biologics
Compare Stelara vs Remicade for Crohn's disease: effectiveness, infection risk, dosing and switching guidance. Prepare to choose with your GI.
Stelara vs Remicade for Ulcerative Colitis: A Comparison
Comparing Stelara and Remicade for UC? Review remission evidence, 4% vs 7% serious infection hospitalizations, dosing and switching guidance.
Symptoms Return Before Your Next Biologic Dose: What to Track and Report
Biologic wearing off before your next dose? Track symptoms, dose dates and biomarkers across 3 to 4 cycles, then prepare a clear report for your GI.
Therapeutic Drug Monitoring (TDM)
Therapeutic drug monitoring for IBD measures biologic trough levels and antibodies. Learn how reactive and proactive TDM guide dosing or switching.
Tremfya vs Entyvio for Crohn's Disease: How They Compare
Tremfya vs Entyvio for Crohn's: compare efficacy, safety, onset timelines at weeks 12 and 14, plus IV and SC dosing, to prepare for your GI visit.
Tremfya vs Entyvio for Ulcerative Colitis: A Comparison
Compare Tremfya and Entyvio for ulcerative colitis by remission data, onset, infection risk, and IV or SC dosing, then prepare questions for your GI.
Tremfya vs Humira for Crohn's Disease: Key Differences
Tremfya vs Humira for Crohn's: compare efficacy, onset, infection risks, dosing, and cost, including SC or IV induction and biosimilar access.
Tremfya vs Humira for Ulcerative Colitis: Which Is Right?
Tremfya vs Humira for ulcerative colitis: compare trial evidence, onset, safety, dosing and cost, then prepare key questions for your GI.
Tremfya vs Omvoh for Crohn's Disease: Key Differences
Tremfya vs Omvoh for Crohn's disease: compare trial evidence, induction routes, dosing, injections and safety, then prepare to talk with your GI.